Hidehiro Fukuyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hidehiro Fukuyama has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Chieko Makino-Okamura
Division of Immunology, Near-InfraRed Photo-Immunotherapy Research Institute, Kansai Medical University, Hirakata, Osaka, Japan
1 shared publicationChika Yamamoto
General Incorporated Association for Comprehensive Disaster Health Management Research Institute, Tokyo, Japan
1 shared publicationEiki Kawahara
Division of Immunology, Near-InfraRed Photo-Immunotherapy Research Institute, Kansai Medical University, Hirakata, Osaka, Japan
1 shared publicationHarumichi Ishigame
Division of Immunology, Near-InfraRed Photo-Immunotherapy Research Institute, Kansai Medical University, Hirakata, Osaka, Japan
1 shared publicationHiroki Yoshimura
General Incorporated Association for Comprehensive Disaster Health Management Research Institute, Tokyo, Japan
1 shared publicationIsato Yamazaki
Division of Immunology, Near-InfraRed Photo-Immunotherapy Research Institute, Kansai Medical University, Hirakata, Osaka, Japan
1 shared publication
Latest Publications
- Open Access
- 18 March 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1337520
Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan
This study investigates the neutralizing activity against the XBB1.5 variant and the ancestral strain in a population post-bivalent vaccination using a pseudo virus assay validated with authentic virus assay. While bivalent booster vaccination and past infections enhanced neutralization against the XBB 1.5 strain, individuals with comorbidities showed reduced responses. The study suggests the need for continuous vaccine updates to address emerging SARS-CoV-2 variants and highlights the importance of monitoring real-world immune responses.
- 18 March 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1337520
Open AccessDiminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan
This study investigates the neutralizing activity against the XBB1.5 variant and the ancestral strain in a population post-bivalent vaccination using a pseudo virus assay validated with authentic virus assay. While bivalent booster vaccination and past infections enhanced neutralization against the XBB 1.5 strain, individuals with comorbidities showed reduced responses. The study suggests the need for continuous vaccine updates to address emerging SARS-CoV-2 variants and highlights the importance of monitoring real-world immune responses.